Skip to main content
. 2023 Aug 12;51(6):1773–1786. doi: 10.1007/s15010-023-02082-z

Table 1.

Characteristic of the study population with sepsis (2008–2021), including subgroups

Sepsisa Subgroups of sepsis
Implicitb Explicitc COVID-19-relatedd
Characteristics
 First admission, n (% of all) 222,832 (100) 127,059 (57.0) 92,928 (41.7) 2845 (1.3)
 Male, n (%) 120,442 (54.1) 66,929 (52.7) 51,651 (55.6) 1862 (65.5)
 Mean age, years (SD) 71.1 (16.6) 73.0 (15.7) 68.9 (17.5) 61.4 (16.1)
Comorbidities, n (%)
 Heart and vascular 100,062 (44.9) 61,251 (48.2) 38,109 (41.0) 702 (24.7)
 Cancer 39,368 (17.7) 17,270 (13.6) 21,973 (23.6) 125 (4.4)
 Lung 36,165 (16.2) 26,993 (21.2) 8866 (9.5) 306 (10.8)
 Renal 8949 (4.0) 5830 (4.6) 3043 (3.3) 76 (2.7)
 Diabetes 24,416 (10.9) 13,682 (10.8) 10,348 (11.1) 386 (13.6)
 Dementia 8100 (3.6) 4561 (3.6) 3507 (3.8) 32 (1.1)
 Immune 3140 (1.4) 1640 (1.3) 1451 (1 0.6) 49 (1.7)
 Liver 994 (0.5) 564 (0.4) 427 (0.5)  ≤ 5
Number of comorbidities, n (%)
 0 68,450 (30.7) 36,185 (28.5) 30,684 (33.0) 1581(55.6)
 1 98,803 (44.3) 56,884 (44.7) 41,050 (44.2) 909 (32.0)
 2 45,352 (20.4) 27,768 (21.9) 17,284 (18.6) 300 (10.5)
  ≥ 3 10,227 (4.6) 6262 (4.9) 3910 (4.2) 55 (1.9)
Site of infection, n (%)
 Respiratory 81,881 (36.8) 63,724 (50.2) 15,566 (16.8) 2591 (91.1)
 Genitourinary 44,782 (20.1) 28,838 (22.7) 15,862 (17.1) 82 (2.9)
 Skin and soft tissue 8265 (3.7) 3578 (2.8) 4682 (5.0) 5 (0.2)
 Gastrointestinal 10,810 (4.8) 8356 (6.6) 2424 (2.6) 30 (1.1)
 Intra-abdominal 12,340 (5.5) 5401 (4.3) 6917 (7.4) 22 (0.8)
 Infections following a procedure 8290 (3.7) 4042 (3.2) 4235 (4.6) 13 (0.5)
 Endocarditis/myocarditis 2530 (1.1) 1008 (0.8) 1514 (1.6) 8 (0.3)
 Othere 43,085 (19.3) 24,463 (19.3) 18,434 (19.8) 188 (6.6)
Organ system with acute dysfunction, n (%)
 Respiratory 61,864 (27.8) 51,453 (40.5) 8012 (8.6) 2399 (84.3)
 Circulatory 14,892 (6.7) 10,647 (8.4) 4177 (4.5) 68 (2.4)
 Renal 67,242 (30.2) 54,295 (42.7) 12,514 (13.5) 433 (15.2)
 Hepatic 3209 (1.4) 2178 (1.7) 1014 (1.1) 17 (0.6)
 Coagulation 6471(2.9) 3858 (3.1) 2570 (2.8) 43 (1.5)
 Otherf 22,173 (10.0) 20,095 (15.8) 1928 (2.1) 150 (5.3)
Number of acute organ dysfunctions, n (%)
 1 133,808 (87.7) 113,998 (89.7) 17,339 (76.0) 2471 (86.9)
 2 15,262 (10.0) 11,038 (8.7) 3955 (17.3) 269 (9.5)
 3 2864 (1.9) 1693 (1.3) 1144 (5.0) 27 (0.9)
  ≥ 4 699 (0.5) 330 (0.3) 264 (1.6)  ≤ 5
Number of hospital admissions for sepsisg, n (%)
 1 171,619 (77.0) 97,105 (76.4) 71,800 (77.3) 2714 (95.4)
 2 33,221 (14.9) 19,339 (15.2) 13,757 (14.8) 125 (4.4)
 3 10,129 (4.6) 5917 (4.7) 4208 (4.5)  ≤ 5
 4 4011 (1.8) 2363 (1.9) 1647 (1.8)  ≤ 5
  ≥ 5 3852 (1.7) 2335 (1.8) 1516 (1.6)  ≤ 5
 Readmissionh, n (%) 55,441 (24.9) 30,895 (24.3) 24,072 (25.9) 474 (16.7)
 ICU treatmentj, n (%) 10,602 (8.5) 6946 (8.7) 3341 (7.9) 315 (11.1)
 In-hospital death, n (%) 30,276 (13.6) 16,273 (12.8) 13,751 (14.8) 352 (12.4)

ICU intensive care unit

aSepsis = All first sepsis admissions in the period 2008–2021, including implicit, explicit and COVID-19-related sepsis (2020–2021)

bImplicit sepsis = ICD-10 code for infection in combination with a code for acute organ function, excluding those who had an explicit code at the same hospital admission

cExplicit sepsis = ICD-10 code for specific sepsis, including those who also had an implicit code at the same admission

dCOVID-19-related sepsis = ICD-10 code for COVID-19 in combination with an acute organ dysfunction code and/or a specific sepsis code

eOther infections = Bone, obstetric, upper airway, central nervous system and unknown

fOther acute organ dysfunction = Acidosis, unspecific gangrene, central nervous system dysfunctions and Systemic Inflammatory Response Syndrome

gNumber of hospital admissions = Calculated as new sepsis admission if admission with ICD-10 codes defining sepsis, regardless of time frame for the new sepsis admission

hReadmission = admission within 30 days after discharge regardless of cause

jVariable calculated from May 1, 2014